Objective: To investigate the relationship between serum TSH concentrations within the accepted reference range and cardiovascular risk.
Main outcome: This study demonstrates that, within the reference range, increasing TSH concentrations are associated with increasing risk parameters for the development of cardiovascular disease. Subjects with TSH concentrations in the uppermost quartile of the reference range had significantly increased waist circumference, BMI, glucose, triglyceride, and systolic blood pressure measurements when compared to those in the lowermost quartile. Furthermore, significant relationships between TSH and waist circumference, BMI, and fasting glucose and triglyceride concentrations were demonstrated. Finally, independent relationships between TSH and both fasting glucose and triglyceride concentrations were demonstrated.
Conclusion:
Within the reference range, increasing TSH concentrations are associated with increasing cardiovascular risk parameters. Fasting glucose and triglycerides have been shown to be independently associated with TSH concentration.
COMMENT
The present study deals with two important issues, namely whether the true reference range of serum TSH should be narrowed to 0.4-2.5 mU/L (instead of the classical 0.4-4.0 mU/L) and consequently, where the limit of what we refer to as "subtle subclinical thyroid underfunction" should be set. The present study compared cardiovascular risk parameters' assessment in healthy female subjects with a serum TSH of 0.50-1.31 mU/L (lower quartile) to those with a serum TSH of 2.61-4.49 mU/L (upper quartile) and the results showed a clear association between a higher serum TSH and increased cardiovascular risk. The increased cardiovascular risk could therefore represent the first step in pathological changes associated with preclinical hypothyroidism. Unfortunately, the authors did not show any data concerning free T4 measurements, which would have helped define a risk truly related to thyroid underfunction. Also, they did not show the data obtained in the two intermediate quartiles, which would have helped delineating whether such an association was a 'continuous' phenomenon or an 'onoff' phenomenon with a threshold when serum TSH reaches or exceeds 2.50 mU/L. In any event and despite these inherent weaknesses, the association demonstrated herein is congruent with data recently published by Asvold et al. (see Thyroid Update 2007, second trimester, article N° 5) where it was shown that increasing serum TSH, within the reference limits, was associated with a deteriorating lipid profile. In the 'hot' controversy surrounding those who believe (or not) that the truly normal TSH range should be narrowed, the present study adds a strong argument to the group of the 'believers' (to which the present author has belonged since many years). See Table below 
